February 3, 2026
How Euro-BioImaging tools support FAIR data upload to BioImage Archive
There’s a new marine sample dataset on the BioImage Archive, thanks to Tina Wiegand and her colleagues, part…
We will host the Special Edition Virtual Pub "Imaging Organoids" on Friday, January 30, from 1-3 pm CET. It will focus on methods used to image organoid systems. As part of this event, Asrar Ali Khan, Infrafrontier, will give a talk entitled "Introduction to the PRIM-TECH3R project" (description below). Join us to hear this and other exciting presentations introducing a range of methods used to image organoid systems - from lung buds to mini-brains.
Title: Introduction to the PRIM-TECH3R project
Presenter: Asrar Ali Khan, Infrafrontier
The EU-funded PRIM-TECH3R project, coordinated by Infrafrontier ERIC, brings together experts to develop and validate new complex in vitro models (CIVMs) as an alternative and support to mouse models used in research to understand and develop treatments for human diseases. PRIM-TECH3R leverages advanced technologies to develop reliable mouse and human CIVMs for preclinical studies, aiming to reduce and refine the use of animal models. Through standardised protocols and robust validation procedures, the project will create state-of-the-art in vitro models from mouse disease models, complementing existing in vivo models. The project will establish a comprehensive repository of preclinical resources, ensure open access, and foster collaboration between research infrastructures and the biomedical industry. Training programmes will equip personnel with the necessary skills to provide CIVMs to the research community. By achieving these objectives, PRIM-TECH3R aims to advance the state-of-the-art in research infrastructures, facilitate industrial exploitation, and contribute to transformative changes in biomedical research practices.

February 3, 2026
There’s a new marine sample dataset on the BioImage Archive, thanks to Tina Wiegand and her colleagues, part…
February 3, 2026
Breast cancer remains one of the most common cancers worldwide, and HER2-positive tumours — characterised by overexpression of the HER2 receptor — are known…
January 30, 2026
Today’s the last chance to apply for the Euro-BioImaging Scientific Ambassador programme 2026-2027. Three of our current Scientific Ambassadors explain why being part of…